« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 7, Issue 1
, Pages 107-114
, February 2011
C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide
References
- . Oxidative stress and Alzheimer disease: the autophagy connection?. Autophagy. 2006;2:143–145
- Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009;110:376–388
- . AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumor cells. J Cell Mol Med. 2009;13:3644–3654
- . Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc. 1992;40:237–244
- . Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system. Neurobiol Aging. 2000;21:271–281
- . Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci. 2004;226:67–70
- Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg. 1997;56:397–403
- Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors. Mol Pharm. 2008;5:567–578
- Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A. 1997;94:9434–9439
- Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task. J Nanosci Nanotechnol. 2007;7:1479–1485
- . [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5:2578–2585
- . Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med. 2002;33:182–191
- . Computer simulation study of fullerene translocation through lipid membranes. Nat Nanotechnol. 2008;3:363–368
- In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol. 1995;2:385–389
- . Synthesis and anti-inflammation evaluation of new C60 fulleropyrrolidines bearing biologically active xanthine. Bioorg Med Chem Lett. 2008;18:99–103
- . Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent. Bioorg Med Chem. 2008;16:8619–8626
- Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol. 2008;75:1416–1425
- HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood. 2009;114:85–94
- Structure-activity relationship of C6-C3 phenylpropanoids on xanthine oxidase-inhibiting and free radical-scavenging activities. Free Radic Biol Med. 2007;43:1541–1551
- . Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci. 1998;18:4439–4450
- . The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion. 2005;45:82–89
- . Protective effects of Angelica sinensis extract on amyloid β-peptide-induced neurotoxicity. Phytomedicine. 2008;15:710–721
- . Endoplasmic reticulum stress plays critical role in brain damage after cerebral ischemia/reperfusion in rats. Neurotox Res. 2009;17:189–202
- . Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J Biol Chem. 2005;280:19410–19418
- . Altered redox state of luminal pyridine nucleotides facilitates the sensitivity towards oxidative injury and leads to endoplasmic reticulum stress dependent autophagy in HepG2 cells. Int J Biochem Cell Biol. 2010;42:157–166
- Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-β, and Bcl-2. Mol Cell. 2007;25:193–205
- . Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 2008;9:1004–1010
- . A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ. 2009;16:264–277
- The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest. 2008;118:2190–2199
- . Damage targeted to the mitochondrial interior induces autophagy, cell cycle arrest and, only at high doses, apoptosis. Autophagy. 2009;5:743–744
- Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-κB survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J. 2009;276:1291–1306
- . Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis. 2008;15:199–210
- . Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol. 2008;3:83–94
- . The efficacy of pentoxifylline in the treatment of vascular dementia: a systematic review. Alzheimer Dis Assoc Disord. 2003;17:46–54
- . The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol. 2001;98:272–279
- . Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. Exp Cell Res. 1999;247:347–355
- Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation. 2004;109:750–755
- . Reduction of apoptosis in the amygdala by an A2A adenosine receptor agonist following myocardial infarction. Apoptosis. 2006;11:1067–1074
- . Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal. 2009;21:656–664
- Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. ACS Nano. 2009;3:3358–3368
This study was supported by a grant (DOH99-TD-B-111-003) from the Center of Excellence for Clinical Trial and Research in Neuroscience.
This study did not involve human or animal research.
PII: S1549-9634(10)00170-X
doi: 10.1016/j.nano.2010.06.009
© 2011 Elsevier Inc. All rights reserved.
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 7, Issue 1
, Pages 107-114
, February 2011
